CIBC Lowers WELL Health Technologies (TSE:WELL) Price Target to C$5.00

WELL Health Technologies (TSE:WELL) had its target price lowered by stock analysts at CIBC from C$7.00 to C$5.00 in a report released on Wednesday,BayStreet.CA reports. The firm presently has a “neutral” rating on the stock. CIBC’s target price indicates a potential upside of 26.26% from the stock’s previous close.

Other research analysts have also issued research reports about the stock. Ventum Financial dropped their price objective on shares of WELL Health Technologies from C$8.00 to C$7.60 and set a “buy” rating for the company in a report on Wednesday. TD Securities dropped their price target on shares of WELL Health Technologies from C$8.50 to C$7.50 and set a “buy” rating for the company in a research note on Wednesday. Royal Bank of Canada reduced their price objective on shares of WELL Health Technologies from C$8.50 to C$7.50 and set an “outperform” rating on the stock in a research note on Monday, March 31st. Finally, Raymond James raised their target price on WELL Health Technologies from C$10.00 to C$11.00 in a research report on Tuesday, December 17th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, WELL Health Technologies presently has a consensus rating of “Moderate Buy” and an average target price of C$8.08.

WELL Health Technologies Price Performance

Shares of WELL opened at C$3.96 on Wednesday. The company has a quick ratio of 1.02, a current ratio of 1.14 and a debt-to-equity ratio of 46.79. The stock has a market cap of C$989.69 million, a PE ratio of 13.42, a PEG ratio of -1.93 and a beta of 1.20. WELL Health Technologies has a 12-month low of C$3.46 and a 12-month high of C$7.36. The business has a 50-day simple moving average of C$5.11 and a two-hundred day simple moving average of C$5.55.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.